In 2025, DiGirolamo and his colleagues published a study showing that even when radiologists outwardly miss a lung nodule and ...

No one looks forward to a colonoscopy, but for the millions of Americans who refuse screening, a simple blood test could help catch colon cancer. For the first time, the American Cancer Society ...

Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing up to 3% annually.

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting, advanced imaging and artificial intelligence to better monitor how cancer ...

Cancer screening has traditionally relied on tests designed to detect one specific disease at a time. Mammograms screen for breast cancer, colonoscopies look for colorectal cancer, and PSA tests help ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

For decades, cancer screening has relied on tests designed to detect one specific cancer at a time. Mammograms screen for breast cancer, colonoscopies look for colorectal cancer, and PSA tests help ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Windsor patients no longer need to travel far to receive a new, lower-risk prostate cancer examination.